|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 265.30% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $2.19 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Windtree Therapeutics.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.